6-K XBRL

FORM 6-K

Company: Galmed Pharmaceuticals Ltd.
Filed: August 2, 2018
Period of Report: August 2, 2018
Accession Number: 0001144204-18-041524

View Document ↗ View on SEC.gov ↗